Metraipolis › archive › dc_055b76d012bc

Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer — Europe PMC PMID:42123545

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42123545
DOI
10.3390/ijms27093965
License (as archived)
solo-consultazione
Archived
2026-11-01T09:27:42.824Z
SHA-256 of the archived text
b2d049f34cf5aaf977e6bb2849e77447cc8c4116bac9341e6a78f4e060a830b6
Stable URL of this page
https://metraipolis.com/documento/dc_055b76d012bc

How to cite

Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer — Europe PMC PMID:42123545 — Europe PMC (en), https://europepmc.org/article/MED/42123545 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_055b76d012bc (Metraipolis archive dc_055b76d012bc, sha256 b2d049f34cf5aaf977e6bb2849e77447cc8c4116bac9341e6a78f4e060a830b6)
BibTeX
@misc{dc055b76d012bc,
  title = {Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer — Europe PMC PMID:42123545},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42123545},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_055b76d012bc; sha256 b2d049f34cf5aaf977e6bb2849e77447cc8c4116bac9341e6a78f4e060a830b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123545. Agents can read the archived copy with the MCP tool read_document.